Sana Biotechnology (SANA) Current Leases (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Current Leases data on file, last reported at $14.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 14.42% year-over-year to $14.9 million; the trailing twelve-month figure through Mar 2026 stood at $14.9 million (up 14.42% YoY), and the FY2025 full-year result was $14.9 million, up 19.18% from the prior year.
• Current Leases steadied at $14.9 million in Q1 2026, from $14.9 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $14.9 million in Q4 2025 to a low of $9.6 million in Q1 2022.
• A 5-year average of $12.6 million and a median of $12.9 million in 2023 frame the typical range for Current Leases.
• Across the five-year window, Current Leases jumped 146.42% in 2022 and decreased 22.44% in 2024, its largest moves.
• Tracing SANA's Current Leases over 5 years: stood at $12.4 million in 2022, then grew by 6.47% to $13.2 million in 2023, then declined by 5.01% to $12.5 million in 2024, then climbed by 19.18% to $14.9 million in 2025, then decreased by 0.4% to $14.9 million in 2026.
• Business Quant data shows SANA's Current Leases at $14.9 million in Q1 2026, $14.9 million in Q4 2025, and $14.4 million in Q3 2025.